CN104208363A - Chinese medicinal composition for treating hyperostosis - Google Patents
Chinese medicinal composition for treating hyperostosis Download PDFInfo
- Publication number
- CN104208363A CN104208363A CN201410488263.1A CN201410488263A CN104208363A CN 104208363 A CN104208363 A CN 104208363A CN 201410488263 A CN201410488263 A CN 201410488263A CN 104208363 A CN104208363 A CN 104208363A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating hyperostosis. The Chinese medicinal composition comprises raw materials of, by weight, 20-30g of safflowers, 20-30g of wintergreen, 20-30g of bungarus parvus, 10-20g of eucommia barks, 10-20g of radish seeds, 10-20g of pseudo-ginseng, 10-20g of diverse wormwood herb, 10-20g of corydalis tuber, 10-20g of dragon's bloods, 10-20g of Chinese clematis, 8-15g of papaya, 8-12g of achyranthes roots, 8-12g of centipede, 8-12g of kudzuvine roots, 8-12g of bighead atractylodes rhizome, and 8-12g of suberect spatholobus stems. According to the Chinese medicinal composition for treating hyperostosis, the raw materials are well compatible and are capable of strengthening tendons and bones, tonifying the liver and kidney, tonifying qi and the spleen, relaxing tendon and activation collaterals to relieve pain, the Chinese medicinal composition is exact in efficacy for treating hyperostosis, free of side effects, high in curing rate, and worth being clinically popularized and applied.
Description
Technical field
The invention belongs to the field of Chinese medicines, specifically a kind of Chinese medicine composition can treating bone matrix hyperplasia.
Background technology
Bone matrix hyperplasia is also known as osteoarthritis, the commonly encountered diseases of middle-aged and elderly people, frequently-occurring disease, the lighter's extremity are cool, heavy, numb, severe one causes nerve compression, blood vessel is blocked, cause people with maimed person, hemiplegia is at bed, and the healthy of people in their serious harms, affecting work and life, society is the chronic pertinacious disease being difficult to cure depending on bone matrix hyperplasia.
Bone matrix hyperplasia is one of clinical common, multiple disease, and because of its recurrent exerbation, touching difficulty heals and clinical treatment is also rather thorny.Current doctor trained in Western medicine there is no effective medicine to this disease, often adopts anti symptom treatment, as taken the medicine of some antipyretic-antalgics during pain; Numbness person can select vitamin B group class medicine; Arthroncus has hydrops, and person can give therapy such as local extraction hydrops or partial closure etc.But facts have proved that these Therapeutic Method are all undesirable, just take stopgap measures and do not effect a permanent cure, though large drug can the to a certain degree symptom such as alleviating pain, but the state of an illness easily repeatedly, be difficult to radical cure, and Long-term taking medicine causes patient to produce drug dependence.
Summary of the invention
Instant invention overcomes the technical deficiency existed in treatment bone matrix hyperplasia at present, provide a kind of determined curative effect, have no side effect, the high and Chinese medicine composition not easily recurred of clinical cure rate.
The technical solution adopted in the present invention is: a kind of Chinese medicine composition for the treatment of bone matrix hyperplasia, is characterized in that, described Chinese medicine composition is made up of the Chinese herb of following weight portion:
Flos Carthami 20-30 gram, Herba Pyrolae 20-30 gram, Bungarus Parvus 20-30 gram, Cortex Eucommiae 10-20 gram, Semen Raphani 10-20 gram, Radix Notoginseng 10-20 gram, Herba Artemisiae Anomalae 10-20 gram, Rhizoma Corydalis 10-20 gram, Sanguis Draxonis 10-20 gram, Radix Clematidis 10-20 gram, Fructus Chaenomelis 8-15 gram, Radix Achyranthis Bidentatae 8-12 gram, Scolopendra 8-12 gram, Radix Puerariae 8-12 gram, Rhizoma Atractylodis Macrocephalae 8-12 gram, Caulis Spatholobi 8-12 gram.
As this kind of prioritization scheme:
Described Chinese medicine composition is made up of the Chinese herb of following weight portion:
20 grams, Flos Carthami, Herba Pyrolae 20 grams, Bungarus Parvus 20 grams, the Cortex Eucommiae 10 grams, Semen Raphani 10 grams, Radix Notoginseng 10 grams, Herba Artemisiae Anomalae 10 grams, Rhizoma Corydalis 10 grams, Sanguis Draxonis 10 grams, Radix Clematidis 10 grams, Fructus Chaenomelis 8 grams, Radix Achyranthis Bidentatae 8 grams, Scolopendra 8 grams, Radix Puerariae 8 grams, the Rhizoma Atractylodis Macrocephalae 8 grams, Caulis Spatholobi 8 grams.
As this kind of prioritization scheme:
Described Chinese medicine composition is made up of the Chinese herb of following weight portion:
25 grams, Flos Carthami, Herba Pyrolae 25 grams, Bungarus Parvus 25 grams, the Cortex Eucommiae 15 grams, Semen Raphani 15 grams, Radix Notoginseng 15 grams, Herba Artemisiae Anomalae 15 grams, Rhizoma Corydalis 15 grams, Sanguis Draxonis 15 grams, Radix Clematidis 15 grams, Fructus Chaenomelis 12 grams, Radix Achyranthis Bidentatae 10 grams, Scolopendra 10 grams, Radix Puerariae 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Caulis Spatholobi 10 grams.
As this kind of prioritization scheme:
Described Chinese medicine composition is made up of the Chinese herb of following weight portion:
30 grams, Flos Carthami, Herba Pyrolae 30 grams, Bungarus Parvus 30 grams, the Cortex Eucommiae 20 grams, Semen Raphani 20 grams, Radix Notoginseng 20 grams, Herba Artemisiae Anomalae 20 grams, Rhizoma Corydalis 20 grams, Sanguis Draxonis 20 grams, Radix Clematidis 20 grams, Fructus Chaenomelis 15 grams, Radix Achyranthis Bidentatae 12 grams, Scolopendra 12 grams, Radix Puerariae 12 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Caulis Spatholobi 12 grams.
The instructions of taking of Chinese medicine composition of the present invention is: after being mixed by the raw material Chinese medicine of above-mentioned weight proportion, 1 dose/day, every agent head decocts the 400ml that adds water, and warm fire boils 25 minutes, extracting juice 200ml; Two decoct the 300ml that adds water, and warm fire boils 20 minutes, extracting juice 150ml.Two decoct mixing, sooner or later empty stomach decoction being taken hot.It within 30 days, was 1 course for the treatment of.
The raw material Chinese medicine of above-mentioned Chinese medicine composition:
Flos Carthami, acrid in the mouth, warm in nature; GUIXIN, Liver Channel.There is promoting blood circulation to restore menstrual flow, effect of eliminating stasis to stop pain.
Herba Pyrolae, sweet in the mouth, hardship, warm in nature; Return lung, stomach, liver, kidney channel.There is tonify deficiency kidney tonifying, expelling wind and removing dampness, effect of promoting blood flow to regulate menstruation.
Bungarus Parvus, salty in the mouth, warm in nature; Return liver, spleen channel.There is dispelling wind and removing obstruction in the collateral, effect of arresting convulsion pain relieving.
The Cortex Eucommiae, sweet in the mouth, warm in nature; Return liver, kidney channel.Have liver and kidney tonifying, strong muscle is active, determines effect that gas is calmed the nerves.
Semen Raphani, acrid in the mouth, sweet, property is put down; Return spleen, stomach, lung meridian.There is the de-swelling that helps digestion, effect of lowering the adverse-rising QI to resolve phlegm.
Radix Notoginseng, sweet in the mouth, micro-hardship, warm in nature; Return liver, stomach warp.There is dissipating blood stasis hemostasis, subduing swelling and relieving pain, hepatoprotective of invigorating blood circulation, effect of recuperating the depleted YANG to cure collapse-syndrome as emergency treatment.
Herba Artemisiae Anomalae, acrid in the mouth, hardship, property is put down; Return lung, spleen channel.There is clearing away summer-heat and eliminating dampness, blood circulation promoting competent silt, effect of inducing menstruation to relieve menalgia.
Rhizoma Corydalis, acrid in the mouth, hardship, warm in nature; Return liver, spleen channel.There is regulating QI to relieve pain, effect of promoting blood circulation to remove blood stasis.
Sanguis Draxonis, salty in the mouth, sweet, property is put down; GUIXIN, Liver Channel.There is blood activating and promoting tissue regeneration, effect of dissipating blood stasis analgesic therapy.
Radix Clematidis is acrid in the mouth, salty, warm in nature; Return urinary bladder channel.There is wind-damp dispelling, the meridian dredging, effect of stopping numbness pain.
Fructus Chaenomelis, warm in nature, sour in the mouth; Return liver, spleen channel.There is relaxing muscles and tendons and activating QI and blood in the collateral, effect of removing dampness to restore normal function of the stomach.
Radix Achyranthis Bidentatae, bitter in the mouth, acid, property is put down; Return liver, kidney channel.Dredge profit descending, can complementary energy let out.There is blood circulation promoting and blood stasis dispelling, invigorating the liver and kidney, bone and muscle strengthening, conducting blood to flow downwards, effect of inducing diuresis for treating stranguria syndrome.
Scolopendra, acrid in the mouth, warm in nature; Return Liver Channel.There is relieving spasm by subduing liver-wind, detoxicating and resolving stagnation of pathogens, effect of removing obstruction in the collateral to relieve pain.
Radix Puerariae, sweet in the mouth, pungent, cool in nature; Attach to the lung and stomach meridians.There is expelling pathogenic factors from muscles for reducing heat, treating measles, promoting the production of body fluid to quench thirst, effect of yang invigorating antidiarrheal.
The Rhizoma Atractylodis Macrocephalae, sweet in the mouth, hardship, warm in nature; Return spleen, stomach warp.There is invigorating the spleen and replenishing QI, dampness diuretic, effect of strengthening superficial resistance to stop perspiration.
Caulis Spatholobi, bitter in the mouth, sweet, temperature; Return liver, kidney channel.Having enriches blood invigorates blood circulation, effect of relaxing muscles and tendons and activating QI and blood in the collateral.
Bone matrix hyperplasia belongs to motherland's medical science " rheumatism involving the bone " category, and this disease is many because of Liver and kidney asthenia of essence and blood, or has held anemofrigid-damp arthralgia resistance under the arm, and QI-blood circulation is unfavorable, and meridians are smooth, causes muscles and bones eventually and loses foster, sclerotin degeneration hypertrophy.Due to local compression or the stimulation of the sclerotin of hypertrophy, affected part tendon fascia is nervous, peripheral nerve pressurized, and meridian qi and blood runs and is obstructed, so affected part pain, and function limitation.
In Chinese medicine composition of the present invention, Flos Carthami, Sanguis Draxonis, Radix Notoginseng can blood activating and promoting tissue regenerations, eliminating stasis to stop pain; Herba Pyrolae, Bungarus Parvus can soothing livers and strengthening spleens, promoting blood circulation to remove obstruction in the collateral; Radix Achyranthis Bidentatae, the Cortex Eucommiae, Caulis Spatholobi can benefiting QI for strengthening the superficies, bone and muscle strengthening, liver and kidney tonifying, and it is descending to dredge profit, and reinforcement and elimination in combination, improves body equilibrium between yin and yang.Semen Raphani, Herba Artemisiae Anomalae, Rhizoma Corydalis can promoting blood circulation to remove obstruction in the collateral, regulating QI to relieve pain, damp eliminating blood stasis dispelling; Radix Clematidis, Fructus Chaenomelis, Scolopendra can dispel the wind removing dampness, channels sootheing and network vessel quickening, detoxicating and resolving stagnation of pathogens; Radix Puerariae, Rhizoma Atractylodis Macrocephalae invigorating the spleen and regulating the stomach, benefiting QI for strengthening the superficies, tonifying Qi and lifting yang, spleen is the congenital foundation, and the function of spleen is normal, is promoted that other function is recovered.All medicine compatibilities are superior, play bone and muscle strengthening altogether, liver and kidney tonifying, and QI invigorating spleen reinforcing is nourished blood, relax the effect of the pain relieving through dredging collateral, medicine arrives in body, can effective reduction of patient tendon anxiety, improves blood circulation, remove microcirculation disturbance, thus the pain of bone matrix hyperplasia is disappeared, functional rehabilitation.
For investigating clinical efficacy and the safety of medicine of the present invention further, we select 86 routine out-patients to carry out clinical trial, wherein man 49 example, female 37 example; Age 24-80 year, average 40 years old; Course of disease 2-25, average 9.1 years.Hyperosteogeny of cervical vertebra person 25 example, lumbar vertebra hyperosteogeny person 20 example, knee joint hyperosteogeny person 15 example, heel bone hyperosteogeny person 20 example.All suffer from all have following symptom: (1) has a dull ache from the beginning of knee joint, joint stuffiness, and light activity is slightly alleviated, and climate change increases the weight of, and does not repeatedly touchingly heal; (2) insidious onset, morbidity is slow, how common middle-aged and elderly people; (3) knee can mild swelling, and time movable, often there are clickly sound and grating in joint; (4) the visible osteoporosis of x-ray inspection, joint space narrows, subchondral bony sclerosis, and edge lip sample changes, and hyperosteogeny is formed.
Criterion of therapeutical effect:
Cure: Clinical Pain transference cure, joint movement function is normal.
Effective: Clinical Pain symptom disappears substantially, and joint movement function is normal.
Effective: Clinical Pain symptom alleviates kind to some extent, and joint motion slightly takes a turn for the better.
Invalid: Clinical Pain symptom is improved not obvious, and joint movement disorder is unchanged, very then increases the weight of.
Therapeutic Method:
After being mixed by the raw material Chinese medicine of above-mentioned weight proportion, add water fried, every agent head decocts the 400ml that adds water, and warm fire boils 25 minutes, extracting juice 200ml; Two decoct the 300ml that adds water, and warm fire boils 20 minutes, extracting juice 150ml.Two decoct mixing, every day 1 dose, point morning and evening 2 decoction being taken hot.It within 30 days, was 1 course for the treatment of.
Efficacy result:
1. clinical efficacy result:
After treatment, cure 40 examples, effective 23 examples, effective 19 examples, invalid 4 examples; Cure rate 46.5%, obvious effective rate 26.7%, effective percentage 22.1%, inefficiency 4.7%, total effective rate 95.3%.Detailed results is in table 1.
Table 1: clinical efficacy result synopsis after treatment
| Number of cases | Cure n (%) | Effective n (%) | Effective n (%) | Invalid n (%) | Effective percentage n (%) |
| 86 | 40(46.5) | 23(26.7) | 19(22.1) | 4(4.7) | 82(95.3) |
2. neck, waist, knee joint, heel bone hyperosteogeny efficacy result:
After treatment, statistics finds, neck, lumbar vertebra hyperosteogeny effective percentage are 100%, and knee joint hyperosteogeny effective percentage is 93.3%, and heel bone hyperosteogeny effective percentage is 90.0%, and it is evident in efficacy to treat various hyperosteogeny.Detailed results is in table 2.
Table 2: neck, waist, knee joint, heel bone hyperosteogeny efficacy result synopsis
| Disease title | Number of cases n | Cure n | Effective n | Effective n | Invalid n | Effective percentage (%) |
| Hyperosteogeny of cervical vertebra | 25 | 12 | 6 | 7 | 0 | 100 |
| Lumbar vertebra hyperosteogeny | 20 | 11 | 8 | 1 | 0 | 100 |
| Knee joint hyperosteogeny | 15 | 10 | 2 | 2 | 1 | 93.3 |
| Heel bone hyperosteogeny | 20 | 13 | 4 | 1 | 2 | 90.0 |
3. side effect reaction
In the treatment, all there is not obvious adverse reaction in all patients.
Result shows, after Chinese medicine composition of the present invention is taken, effectively can promote local blood circulation, makes it to balance each other with whole body microcirculation, corrects dysequilibrium, reaches and eliminates the symptom such as hyperosteogeny symptom and intervertebral disk hernia, reaches the object of thoroughly curing.Clinical practice finds, Drug therapy neck of the present invention, waist, knee joint, heel bone hyperosteogeny disease determined curative effect, taking convenience, has no side effect, clinic promotion and application.
Detailed description of the invention
Embodiment 1: a kind of Chinese medicine composition for the treatment of bone matrix hyperplasia, chooses 20 grams, Flos Carthami, Herba Pyrolae 20 grams, Bungarus Parvus 20 grams, the Cortex Eucommiae 10 grams, Semen Raphani 10 grams, Radix Notoginseng 10 grams, Herba Artemisiae Anomalae 10 grams, Rhizoma Corydalis 10 grams, Sanguis Draxonis 10 grams, Radix Clematidis 10 grams, Fructus Chaenomelis 8 grams, Radix Achyranthis Bidentatae 8 grams, Scolopendra 8 grams, Radix Puerariae 8 grams, the Rhizoma Atractylodis Macrocephalae 8 grams, Caulis Spatholobi 8 grams.
Embodiment 2: a kind of Chinese medicine composition for the treatment of bone matrix hyperplasia, chooses 25 grams, Flos Carthami, Herba Pyrolae 25 grams, Bungarus Parvus 25 grams, the Cortex Eucommiae 15 grams, Semen Raphani 15 grams, Radix Notoginseng 15 grams, Herba Artemisiae Anomalae 15 grams, Rhizoma Corydalis 15 grams, Sanguis Draxonis 15 grams, Radix Clematidis 15 grams, Fructus Chaenomelis 12 grams, Radix Achyranthis Bidentatae 10 grams, Scolopendra 10 grams, Radix Puerariae 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Caulis Spatholobi 10 grams.
Embodiment 3: a kind of Chinese medicine composition for the treatment of bone matrix hyperplasia, chooses 30 grams, Flos Carthami, Herba Pyrolae 30 grams, Bungarus Parvus 30 grams, the Cortex Eucommiae 20 grams, Semen Raphani 20 grams, Radix Notoginseng 20 grams, Herba Artemisiae Anomalae 20 grams, Rhizoma Corydalis 20 grams, Sanguis Draxonis 20 grams, Radix Clematidis 20 grams, Fructus Chaenomelis 15 grams, Radix Achyranthis Bidentatae 12 grams, Scolopendra 12 grams, Radix Puerariae 12 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Caulis Spatholobi 12 grams.
Below by concrete case, Chinese medicine composition curative effect of the present invention is verified further:
Case 1
Zhang, female, 63 years old, patient suffers from 1 to 5 joint hyperosteogeny, and lumbago is more than 4 years, for many years, employing Chinese medicine, western medicine all obviously do not improve, patient still with pain in the lumbar region, right lower limb thigh and shank pain numbness, the symptoms such as dysstasia, due to hyperosteogeny nerve compression, cause right femur to thigh and shank heel pain numbness all day, will slowly just can stand after sitting down, minimal invasive treatment is agonizing.Upon somebody's introduction, start trial and take Chinese medicine composition of the present invention and treat, after 1 course for the treatment of, patient's readme pain and tingle symptom alleviate, and start feeling relaxed when standing; After continuing to take 1 curative effect, patient clinical symptom disappears completely, can normal stand, continues to take medicine after treatment in addition in 2 weeks, Rehabilitation.Follow up a case by regular visits to and have no recurrence half a year.
Case 2
Liu, man, 58 years old, patient without the obvious inducement sensation neck shoulder back of the body and two upper limb numbness, pain, took the photograph sheet inspection through hospital's X-ray and is diagnosed as: hyperosteogeny of cervical vertebra before 3 years.Fail to respond to any medical treatment through TDP Infrared radiation, cervical traction etc., patient is with restriction of neck motion, dizzy uncomfortable, and hand-grip strength such as to weaken at the symptom.Start to take medicine of the present invention upon somebody's introduction to treat, after 2 courses for the treatment of, the transference cures such as acid, fiber crops, pain, freely, various functions recovers normal in cervical region activity.Follow up a case by regular visits to and have no a recurrence in.
Case 3
Health, man, 47 years old.Patient is pain and swelling after right sprain of knee joint the year before, rear pain increases the weight of gradually, the warm fear of cold of happiness, joint stuffiness, upper difficulty downstairs, stiff about 5 minutes of morning, on inspection: right knee joint mild swelling, local skin temperature rise, audible and bony crepitus when song is stretched, X-ray film checks finding: multiple moderate bony spur, is diagnosed as knee joint hyperosteogeny disease.Take Chinese medicine composition of the present invention, after treating 1 course for the treatment of, symptom obviously alleviates, and joint motion pain is not obvious, and continual cure is Clinical Pain swelling transference cure after 2 weeks, continues to strengthen treatment 2 weeks, and X sheet is checked, and bony spur passivation, patient articular's activity freely.Follow up a case by regular visits to and have no recurrence half a year.
Claims (4)
1. treat a Chinese medicine composition for bone matrix hyperplasia, it is characterized in that, described Chinese medicine composition is made up of the Chinese herb of following weight portion:
Flos Carthami 20-30 gram, Herba Pyrolae 20-30 gram, Bungarus Parvus 20-30 gram, Cortex Eucommiae 10-20 gram, Semen Raphani 10-20 gram, Radix Notoginseng 10-20 gram, Herba Artemisiae Anomalae 10-20 gram, Rhizoma Corydalis 10-20 gram, Sanguis Draxonis 10-20 gram, Radix Clematidis 10-20 gram, Fructus Chaenomelis 8-15 gram, Radix Achyranthis Bidentatae 8-12 gram, Scolopendra 8-12 gram, Radix Puerariae 8-12 gram, Rhizoma Atractylodis Macrocephalae 8-12 gram, Caulis Spatholobi 8-12 gram.
2. Chinese medicine composition according to claim 1, is characterized in that, described Chinese medicine composition is made up of the raw material of following weight portion:
20 grams, Flos Carthami, Herba Pyrolae 20 grams, Bungarus Parvus 20 grams, the Cortex Eucommiae 10 grams, Semen Raphani 10 grams, Radix Notoginseng 10 grams, Herba Artemisiae Anomalae 10 grams, Rhizoma Corydalis 10 grams, Sanguis Draxonis 10 grams, Radix Clematidis 10 grams, Fructus Chaenomelis 8 grams, Radix Achyranthis Bidentatae 8 grams, Scolopendra 8 grams, Radix Puerariae 8 grams, the Rhizoma Atractylodis Macrocephalae 8 grams, Caulis Spatholobi 8 grams.
3. Chinese medicine composition according to claim 1, is characterized in that, described Chinese medicine composition is made up of the raw material of following weight portion:
25 grams, Flos Carthami, Herba Pyrolae 25 grams, Bungarus Parvus 25 grams, the Cortex Eucommiae 15 grams, Semen Raphani 15 grams, Radix Notoginseng 15 grams, Herba Artemisiae Anomalae 15 grams, Rhizoma Corydalis 15 grams, Sanguis Draxonis 15 grams, Radix Clematidis 15 grams, Fructus Chaenomelis 12 grams, Radix Achyranthis Bidentatae 10 grams, Scolopendra 10 grams, Radix Puerariae 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Caulis Spatholobi 10 grams.
4. Chinese medicine composition according to claim 1, is characterized in that, described Chinese medicine composition is made up of the raw material of following weight portion:
30 grams, Flos Carthami, Herba Pyrolae 30 grams, Bungarus Parvus 30 grams, the Cortex Eucommiae 20 grams, Semen Raphani 20 grams, Radix Notoginseng 20 grams, Herba Artemisiae Anomalae 20 grams, Rhizoma Corydalis 20 grams, Sanguis Draxonis 20 grams, Radix Clematidis 20 grams, Fructus Chaenomelis 15 grams, Radix Achyranthis Bidentatae 12 grams, Scolopendra 12 grams, Radix Puerariae 12 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Caulis Spatholobi 12 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410488263.1A CN104208363A (en) | 2014-09-23 | 2014-09-23 | Chinese medicinal composition for treating hyperostosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410488263.1A CN104208363A (en) | 2014-09-23 | 2014-09-23 | Chinese medicinal composition for treating hyperostosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104208363A true CN104208363A (en) | 2014-12-17 |
Family
ID=52090536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410488263.1A Pending CN104208363A (en) | 2014-09-23 | 2014-09-23 | Chinese medicinal composition for treating hyperostosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104208363A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1150910A (en) * | 1996-04-18 | 1997-06-04 | 花茂时 | Osteophytosis pill and its compounding method |
| CN103908545A (en) * | 2014-01-15 | 2014-07-09 | 陈其聪 | Drug for treating cervical and lumbar vertebra and knee hyperosteogeny and lumbar disc herniation |
-
2014
- 2014-09-23 CN CN201410488263.1A patent/CN104208363A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1150910A (en) * | 1996-04-18 | 1997-06-04 | 花茂时 | Osteophytosis pill and its compounding method |
| CN103908545A (en) * | 2014-01-15 | 2014-07-09 | 陈其聪 | Drug for treating cervical and lumbar vertebra and knee hyperosteogeny and lumbar disc herniation |
Non-Patent Citations (2)
| Title |
|---|
| 彭力亚: "自拟骨痹汤治疗骨质增生120例临床观察", 《中国中医基础医学杂志》 * |
| 邹世光等: "中药内服外敷治疗骨质增生症510例", 《湖北中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411802B (en) | Black plaster for treating hyperosteogeny and preparation method thereof | |
| CN101850026B (en) | Hot compress medicament package for treating lumbar intervertebral disc protrusion, lumbar muscle strain and soft tissue injury | |
| CN104083457A (en) | Orthopaedic medicinal liquor for treating qi deficiency and body weakness type lumbar muscle strain and preparation method | |
| CN106039245A (en) | External traditional Chinese medicine mineral spring mud for treating rheumatoid bone diseases and preparation method thereof | |
| CN104383030A (en) | Traditional Chinese medicine preparation for treating gonarthromeningitis | |
| CN101293041B (en) | Externally used medicament for treating protrusion of lumbar vertebral disc, spinal canal stenosis | |
| CN103446360B (en) | Traditional Chinese medicine capsule preparation for treating lumbar disc herniation and preparation method of traditional Chinese medicine capsule preparation | |
| CN103446386B (en) | A kind of Chinese medicine composition for the treatment of lumbago | |
| CN1418696A (en) | Traditional Chinese medicine prepn. for treating cervical vertebra disease | |
| CN102188540B (en) | External liniment for treating cervical vertebra and lumbar vertebra diseases | |
| CN107320698A (en) | A kind of Chinese medicine compound prescription for treating person in middle and old age's nerve root cervical vertebra sickness and its application | |
| CN103536671B (en) | Drug for treating ischialgia | |
| CN105497779A (en) | Traditional Chinese medicine patch for treating acute lumbar sprain | |
| CN103721183B (en) | A kind of Chinese medicine composition for the treatment of middle-aged and elderly people lumbago and skelalgia | |
| CN100589826C (en) | Chinese traditional medicine compound for treating protrusion of lumbar intervertebral disc for external application | |
| CN104258285A (en) | Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof | |
| CN104547222A (en) | Traditional Chinese medicine patching agent for treating hyperostosis | |
| CN104208363A (en) | Chinese medicinal composition for treating hyperostosis | |
| CN102218119A (en) | Chinese herbal medicine for treating rheumatism, femoral head necrosis and puerperal fever | |
| CN101028472B (en) | Oral Chinese medicinal composition for treating lumbocostal overstrain | |
| CN106109630A (en) | For treating the Chinese medicine composition of cervical spondylosis | |
| CN104147531A (en) | Traditional Chinese medicine preparation for treating osteoproliferation disease | |
| CN105687542A (en) | Chinese herbal preparation for fracture aftertreatment and preparing method thereof | |
| CN106511828A (en) | Chinese medicinal composition for treatment of acute lumbar sprain | |
| CN104740193A (en) | Traditional Chinese medicine composition for treating neck-shoulder muscle strain syndrome and preparation method of traditional Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141217 |
|
| RJ01 | Rejection of invention patent application after publication |